Corpus overview


MeSH Disease

Human Phenotype


gender (1)


There are no seroprevalence terms in the subcorpus

    displaying 1 - 1 records in total 1
    records per page

    Impact of COVID-19 on outpatient therapy with iloprost for Systemic Sclerosis digital ulcers MESHD digital ulcers HP

    Authors: Francesca Crisafulli; Maria-Grazia Lazzaroni; Stefania Zingarelli; Mara Rossi; Angela Tincani; Franco Franceschini; Paolo Airò

    doi:10.21203/ Date: 2020-07-03 Source: ResearchSquare

    Introduction and objectivesThe outbreak of COVID-19 epidemic imposed temporary changes in the management of patients with chronic diseases MESHD. We analyzed the impact of COVID-19 epidemic in patients with Systemic Sclerosis MESHD ( SSc MESHD) receiving intravenous iloprost infusions for digital ulcers HP ulcers MESHD (DU) treatment.MethodsDuring the epidemic, iloprost infusion therapy in our Hospital was guaranteed; patients were regularly contacted by telephone before the scheduled infusions. DU were evaluated with DUCAS (DU Clinical Assessment Score).ResultsBetween 20th February and 31st May 2020, 47/64 SSc MESHD patients did not receive at least one of the scheduled infusions, for patients fear and/or logistical difficulties (43 cases), COVID-19 (2), or other intercurrent diseases (2). At the last evaluation before 20th February DUCAS was not different between patients who stopped the therapy and those who continued it. The 2 groups had similar rate of new DU MESHD during the emergency period, but DUCAS slightly increased during therapy discontinuation, decreasing after resuming it. After COVID-19, one patient underwent a fingertip sub-amputation, and an 85-year-old male TRANS with multiple comorbidities died for complications related to the infection.ConclusionsMost SSc MESHD patients briefly discontinued iloprost therapy, without increase of new DU number, but with a slight increase of their severity. The regular telephonic contact helped the management that, although not optimal, was adapted to the needs of the individual patient during this emergency period. DUCAS proved to be a useful tool for rheumatologists. COVID-19 had serious consequences in the two patients who contracted it.

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from and is updated on a daily basis (7am CET/CEST).
The web page can also be accessed via API.



MeSH Disease
Human Phenotype

Export subcorpus as...

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.